CEA [CHINA EASTERN AIRLINES] 20-F/A:

[] [DATED rd 23 CHINA EASTERN AIRLINES CORPORATION LIMITED as the seller and AIRBUS S.A.S. as the buyer and CHINA EASTERN AVIATION IMPORT AND EXPORT CORPORATION as the Consenting Party and CHINA EASTERN AIRLINES, WUHAN COMPANY CHINA EASTERN YUNNAN AIRLINES CHINA EASTERN AIRLINES JIANGSU LTD. SHANGHAI AIRLINES COMPANY LIMITED as Sellers AIRCRAFT SALE AND PURCHASE AGREEMENT relating to EIGHT (8) BOMBARDIER]

By | 2016-02-29T05:37:39+00:00 August 19th, 2013|Categories: CEA, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 6-K: (Original Filing)

[UTStarcom Reports Unaudited Financial Results for the Second Quarter of 2013 BEIJING, China, August 16, 2013 — UTStarcom Holdings Corp. (“UTStarcom” or “the Company”) (NASDAQ: UTSI), a leading provider of media operational support services and broadband products and services, today reported its unaudited financial results for the quarter ended June 30, 2013. As previously announced, the Company closed the divestiture] [UTStarcom Holdings Corp. Second Quarter 2013 Results NASDAQ: UTSI August 2013 Mr. William Wong, CEO Mr. Robert Pu, CFO 1 3 Earnings Call Agenda Update on Operating Progress Overview of Second Quarter 2013 Results 1 2 3 Company Outlook 4 Summary of Key Highlights 5 Update on Shareholder Value Initiatives Update on Operating Progress 4 A Summary of Operating Progress]

By | 2016-03-01T10:43:38+00:00 August 19th, 2013|Categories: Chinese Stocks, SEC Original, UTSI|Tags: , , , , , |0 Comments

UTSI [UTSTARCOMS] 6-K: UTStarcom Reports Unaudited Financial Results for the Second

[UTStarcom Reports Unaudited Financial Results for the Second Quarter of 2013 BEIJING, China, August 16, 2013 — UTStarcom Holdings Corp. (“UTStarcom” or “the Company”) (NASDAQ: UTSI), a leading provider of media operational support services and broadband products and services, today reported its unaudited financial results for the quarter ended June 30, 2013. As previously announced, the Company closed the divestiture] [UTStarcom Holdings Corp. Second Quarter 2013 Results NASDAQ: UTSI August 2013 Mr. William Wong, CEO Mr. Robert Pu, CFO 1 3 Earnings Call Agenda Update on Operating Progress Overview of Second Quarter 2013 Results 1 2 3 Company Outlook 4 Summary of Key Highlights 5 Update on Shareholder Value Initiatives Update on Operating Progress 4 A Summary of Operating Progress]

By | 2016-03-01T10:44:44+00:00 August 19th, 2013|Categories: Chinese Stocks, UTSI, Webplus ver|Tags: , , , , , |0 Comments

EVK [Ever-Glory International,] 10-Q: (Original Filing)

[FORM 10-Q x For the quarterly period ended June 30, 2013 o For the transition period from ____________ to ____________ Ever-Glory International Group Inc. Florida 65-0420146 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, People’s Republic of China (8625) 5209-6875 x o Yes x] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2013 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2013 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Chief Finance Officer (Principal Financial Officer) EX-32.2 4 f10q0613ex32ii_everglory.htm CERTIFICATION] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 5 f10q0613ex32i_everglory.htm CERTIFICATION]

EVK [Ever-Glory International,] 10-Q: FORM 10-Q x For the quarterly period ended

[FORM 10-Q x For the quarterly period ended June 30, 2013 o For the transition period from ____________ to ____________ Ever-Glory International Group Inc. Florida 65-0420146 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) Ever-Glory Commercial Center, 509 Chengxin Road, Jiangning Development Zone, Nanjing, Jiangsu Province, People’s Republic of China (8625) 5209-6875 x o Yes x] [I, Edward Yihua Kang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2013 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [I, Jiansong Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ending June 30, 2013 of Ever-Glory International Group, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Chief Finance Officer (Principal Financial Officer) EX-32.2 4 f10q0613ex32ii_everglory.htm CERTIFICATION] [Section 906 of Sarbanes-Oxley Act of 2002 1. 2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company. Edward Yihua Kang Chief Executive Officer EX-32.1 5 f10q0613ex32i_everglory.htm CERTIFICATION]

BSPM [Biostar Pharmaceuticals,] 10-Q: (Original Filing)

[FORM 10-Q (Mark One) x June 30, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By | 2016-03-03T10:57:08+00:00 August 19th, 2013|Categories: BSPM, Chinese Stocks, SEC Original|Tags: , , , , , |0 Comments

BSPM [Biostar Pharmaceuticals,] 10-Q: FORM 10-Q (Mark One) x June 30, 2013

[FORM 10-Q (Mark One) x June 30, 2013 For the quarterly period ended: Or ¨ For the transition period from ______________ to _______________ 001-34708 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-8747899 (State or other jurisdiction of incorporation of origination) (I.R.S. Employer Identification Number) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province People’s Republic of China 712046 (Zip code) 011-86-29-33686638 (Former name, former] [CERTIFICATION I, Ronghua Wang, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION I, Qinghua Liu, certify that: 1. I have reviewed this quarterly report on Form 10-Q of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer EX-32.1 4 ex32-1.htm] [CERTIFICATION (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Qinghua Liu, Interim Chief Financial Officer (Principal Financial and Accounting Officer) EX-32.2 5 ex32-2.htm]

By | 2016-03-03T10:59:16+00:00 August 19th, 2013|Categories: BSPM, Chinese Stocks, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar